Kalbe Farma Tbk Stock Working Capital
| PTKFY Stock | USD 17.03 0.26 1.50% |
Kalbe Farma Tbk fundamentals help investors to digest information that contributes to Kalbe Farma's financial success or failures. It also enables traders to predict the movement of Kalbe Pink Sheet. The fundamental analysis module provides a way to measure Kalbe Farma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kalbe Farma pink sheet.
Kalbe |
Kalbe Farma Tbk Company Working Capital Analysis
Kalbe Farma's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Kalbe Farma Tbk has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—General (which currently averages 0.0) industry. The working capital for all United States stocks is 100.0% higher than that of the company.
Kalbe Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kalbe Farma's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kalbe Farma could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics of similar companies.Kalbe Farma is currently under evaluation in working capital category among related companies.
Kalbe Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Current Valuation | 5.89 B | |||
| Shares Outstanding | 231.28 M | |||
| Price To Earning | 32.31 X | |||
| Price To Book | 4.75 X | |||
| Price To Sales | 3.28 X | |||
| Revenue | 26.26 T | |||
| Gross Profit | 11.11 T | |||
| EBITDA | 4.54 T | |||
| Net Income | 3.18 T | |||
| Cash And Equivalents | 189.29 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 490.28 B | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 4.08 X | |||
| Book Value Per Share | 4.20 X | |||
| Cash Flow From Operations | 2.83 T | |||
| Earnings Per Share | 0.96 X | |||
| Number Of Employees | 12.64 K | |||
| Beta | 0.32 | |||
| Market Capitalization | 7.21 B | |||
| Total Asset | 25.67 T | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.72 % | |||
| Net Asset | 25.67 T |
About Kalbe Farma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kalbe Farma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kalbe Farma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kalbe Farma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kalbe Farma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kalbe Farma's short interest history, or implied volatility extrapolated from Kalbe Farma options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kalbe Farma Tbk using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |